EXT1 antibody (AA 28-171) (Biotin)
Quick Overview for EXT1 antibody (AA 28-171) (Biotin) (ABIN7152306)
Target
See all EXT1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 28-171
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Exostosin-1 protein (28-171AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- EXT1 (Exostosin 1 (EXT1))
-
Alternative Name
- EXT1
-
Background
-
Background: Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).
Aliases: 4-alpha-N-acetylglucosaminyltransferase antibody, exostoses (multiple) 1 antibody, Exostosin 1 antibody, Exostosin glycosyltransferase 1 antibody, Exostosin-1 antibody, EXT antibody, EXT1 antibody, EXT1_HUMAN antibody, Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase antibody, glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan antibody, Langer-Giedion syndrome chromosome region antibody, LGCR antibody, LGS antibody, Multiple exostoses protein 1 antibody, Multiple exostoses protein 1 homolog antibody, N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase antibody, Putative tumor suppressor protein EXT1 antibody, TRPS2 antibody, TTV antibody
-
UniProt
- Q16394
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-